Blockchain Registration Transaction Record

Lantern Pharma Launches AI Tool predictBBB.ai with 94% Accuracy for Brain Drug Development

Lantern Pharma launches predictBBB.ai, an AI tool with 94% accuracy for predicting blood-brain barrier permeability, accelerating CNS drug development and FDA-cleared glioblastoma trials.

This development matters because the blood-brain barrier has been one of the most significant obstacles in treating neurological diseases, including brain cancers, Alzheimer's, and Parkinson's. Current drug development faces a 94-98% failure rate for CNS therapies due to permeability issues. By providing researchers with a tool that accurately predicts which molecules can cross this barrier, Lantern Pharma is potentially accelerating the development of effective treatments for millions suffering from brain-related conditions. The freemium model also democratizes access to this technology, enabling smaller research institutions and pharmaceutical companies to advance their CNS programs more efficiently, ultimately bringing life-saving treatments to market faster.